Showing 9061-9070 of 21419 results for "".
Improving Sleep and Mental Health in Patients with CKD-aP
https://reachmd.com/programs/cme/improving-sleep-and-mental-health-in-patients-with-ckd-ap/36301/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Integrating Patient Perspectives in Dermatologic Care
https://reachmd.com/programs/innovations-in-medicine/patient-perspectives-dermatologic-care/37245/Clinicians are trying to align care with individual patient needs for the approximately eight million American adults and over 125 million people worldwide living with psoriasis.1 In the ENCOMPASS study’s US arm, researchers examined treatment experiences, satisfaction, and perceptions of therapiesChairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
https://reachmd.com/programs/cme/chairpersons-perspective-incorporating-novel-treatment-options-for-schizophrenia-into-clinical-practice-overcoming-clinical-inertia/54751/Learn expert insights on muscarinic antipsychotics in schizophrenia, with practical guidance on patient selection, titration, and managing adverse effects.The New Era of RAS Targeting: Mechanisms, Evidence, and Clinical Integration of ON-State Inhibitors
https://reachmd.com/programs/cme/the-new-era-of-ras-targeting-mechanisms-evidence-and-clinical-integration-of-on-state-inhibitors/39770/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Breaking the Cycle: Understanding and Managing Inflammatory Memory in Psoriasis
https://reachmd.com/programs/clinicians-roundtable/breaking-the-cycle-understanding-and-managing-inflammatory-memory-in-psoriasis/32446/Inflammatory memory may influence symptom recurrence in psoriasis patients. Learn about how it works and strategies for promoting sustained remission.Achieving Success in IgAN & FSGS
https://reachmd.com/programs/cme/achieving-success-in-igan-fsgs/14677/Review underlying mechanisms of glomerulonephritis and sclerosis in patients with IgAN and FSGS and find out how emerging data may improve outcomes.When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
https://reachmd.com/programs/video-library/when-to-start-using-sglt2i-in-hfref-initiating-guideline-recommended-treatment-options/14734/This discussion is part of a series titled "When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options".IBD and Biosimilars: What Healthcare Professionals Need to Know
https://reachmd.com/programs/gi-insights/ibd-and-biosimilars-what-healthcare-professionals-need-to-know/13835/Do you know how the approval of biosimilars will impact the treatment of inflammatory bowel disease? Hear from our experts and stay up to date!Investigating Inflammatory Mediators in Chronic Rhinosinusitis
https://reachmd.com/programs/deep-breaths-updates-chest/investigating-inflammatory-mediators-chronic-rhinosinusitis/13423/Learn more about the role of inflammatory mediators in chronic rhinosinusitis.Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
https://reachmd.com/programs/cme/seeing-the-invisible-radiologic-precision-to-enable-early-intervention-in-bronchiectasis/56384/Join our experts in this engaging broadcast replay and improve your ability to differentiate the radiologic patterns of bronchiectasis from other lung diseases.